Protein-free ligand screening: simplification of chiral chromatographic development via novel adaptation of NMR

Melissa R Thompson1, David R McKenzie, John J Likos

  • 1Pfizer Global Research and Development, St. Louis Laboratories, Saint Louis, MO, USA. Melissa.Thompson@Pfizer.com

Related Concept Videos